Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure

Alkis, N.; Demirci, U.; Benekli, M.; Yilmaz, U.; Isikdogan, A.; Sevinc, A.; Ozdemir, N.; Koca, D.; Yetisyigit, T.; Kaplan, M.; Uncu, D.; ÜNEK, TARKAN; Gumus, M.

Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure

Copy For Citation

Alkis N., Demirci U., Benekli M., Yilmaz U., Isikdogan A., Sevinc A., ...More

JOURNAL OF BUON, vol.16, no.1, pp.80-83, 2011 (SCI-Expanded)

Publication Type: Article / Article
Volume: 16 Issue: 1
Publication Date: 2011
Journal Name: JOURNAL OF BUON
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.80-83
Keywords: fluoropyrimidines, metastatic colorectal cancer, mitomycin-C, salvage therapy, 5-FLUOROURACIL, CHEMOTHERAPY, LEUCOVORIN, FLUOROURACIL, CARCINOMA, TRIAL
Dokuz Eylül University Affiliated: Yes

Abstract

Purpose: To retrospectively evaluate the efficacy and tolerability of mitomycin-C (MMC) in combination with fluoropyrimidines as salvage 3rd -or 4th-line therapy in metastatic colorectal cancer (MCRC) patients.